Innovative and Leading, Gotion High-Tech Empowers Saudi Arabia to Build a Model for Green Zero-Carbon Energy
RIYADH, Saudi Arabia, Oct. 13, 2025 /PRNewswire/ -- At the Solar &…
Plume Joins prpl Foundation to Drive Ecosystem Collaboration and Openness
Committed to providing solutions based on open standards that create business value…
MiTAC Computing Showcases Future-Ready AI Cluster Solutions at the 2025 OCP Global Summit to Empower Open and Energy-Efficient Data Centers
SAN JOSE, Calif., Oct. 13, 2025 /PRNewswire/ -- MiTAC Computing Technology, a…
Merus Announces Petosemtamab in Metastatic Colorectal Cancer Abstract Selected for Plenary Session Oral Presentation at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
- Plenary session oral presentation: Friday, October 24 10:00 -11:40 a.m. ET…
Quanta Therapeutics Announces First Clinical Data Presentation for QTX3034, an Oral G12D-Preferring Multi-KRAS Inhibitor, at 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
RADNOR, Pa. and SOUTH SAN FRANCISCO, Calif., Oct. 13, 2025 (GLOBE NEWSWIRE)…
Collaboration across Bybit, DigiFT and UBS uMINT expands Collateral Solution for Institutions
DUBAI, UAE, Oct. 13, 2025 /PRNewswire/ -- Bybit, the world's second-largest cryptocurrency exchange…
BitMine Immersion (BMNR) Announces ETH Holdings Exceeding 3.03 Million Tokens and Total Crypto and Cash Holdings of $12.9 Billion
BitMine now owns greater than 2.5% of the ETH token supply, now…
Eightco Holdings Inc. ($ORBS) Makes Strategic Investment into Mythical Games to Accelerate Human Verification and Digital Identity in Gaming
Joining strategic round alongside Cathie Wood's ARK Invest and World Proving gamers…
DB-OTO Results in theNew England Journal of Medicine Showcase Dramatic and Sustained Improvements in Hearing and Speech Perception in Children with Profound Genetic Hearing Loss
Nearly all participants (11 of 12) experienced clinically meaningful hearing improvements, including…
Apogee Therapeutics, Inc. Announces Closing of Public Offering and Full Exercise of the Underwriters Option to Purchase Additional Shares for Gross Proceeds of $345 Million
SAN FRANCISCO and BOSTON, Oct. 10, 2025 (GLOBE NEWSWIRE) -- Apogee Therapeutics,…
